andYou're receiving this email because you're subscribed to Cannabis Daily from Benzinga. To manage your subscription, click the link at the bottom of this email.

TGIF Cannabis Investors: A new synthetic opioid, known as the "Frankenstein Drug," is making headlines for its alarming potency. Here is all you need to know about Nitazenes.

Plus, Dua Lipa and the 'High Priestess Of LSD' discuss psychedelics.

On The Go: Check out the newest episode of Cannabis Insider, also available on Apple and Spotify.

Puff Pass: Did someone forward you this email? Click here to get automatically subscribed.

TOP STORY

How To 'Survive In Chaos': From Lab Rats And Eyeballs To Cannabis

Briefly: First, Claudia Post oversaw the safe delivery of eyeballs, kidneys and other organs. Today? Her specialty is cannabis.

Most recently, she launched Scarlet Express, a state-approved, closed-loop delivery organization providing discreet, secure and expert cannabis supply chain management nationwide.

Check out our exclusive interview with Post at the recent Benzinga Cannabis Market Spotlight event here.

PRESENTED BY CANNABIS INSIDER TITANS OF FINANCE

Join the Benzinga Cannabis team and cannabis finance titans, Adam Stettner, Seth Yakatan, and Henry Miller for a special virtual event about the ins and outs of cannabis capital.

ZINGERS

Multi-State Operator News: After Reviewing Current Cannabis Market Conditions, 4Front Withdraws Brokered Offering

Cannabis Europe News: Will UK Cannabis Laws Change Under New Labour Government? Doesn't Look That Way Just Yet

State Regulation: Bipartisan Bill In Michigan Aims To Merge Adult Use And Medical Marijuana Regulations

Corporate News: Craft Weed Company Bets On New Jersey Market, Now Owns 44% Of This State-Licensed Cultivator

Cannabis Sales: Gov. Wes Moore Announces Maryland Cannabis Sales Exceed $1.1B In First Year Of Legalization

ONE MORE FOR THE ROAD

Is Now The Time To Invest In Cannabis Stocks?

Briefly: A federal court recently dismissed a lawsuit from major cannabis companies trying to stop the U.S. government from enforcing prohibition on their in-state activities.

Why It Matters: This decision could have major implications for cannabis stocks and the entire industry.

So: Experts weigh in that U.S. cannabis stocks are highly sensitive to regulatory news and predict a drastic consolidation in the industry over the next decade.

What’s Next: Here’s what we can anticipate for the cannabis industry over the next decade.

PRESENTED BY CANNABIS CAPITAL CONFERENCE

Join us on October 8th and 9th in Chicago for the world's largest gathering of cannabis investors - happening just ONE month before the Presidential election.

Buy your tickets, apply to exhibit or become a sponsor here.

BEFORE YOU GO

Were you forwarded this email? Click here to subscribe.

And be sure to check out our other newsletters:

Ring The Bell: Created for market enthusiasts by market enthusiasts, this twice-daily newsletter delivers top stories, fast movers, and hot trade ideas straight to your inbox. Subscribe here.

Future Finance: Where fintech, crypto, and the future of finance collide. Future Finance is a perfect lunch read packed with quick bites for industry enthusiasts. Subscribe here.

Real Estate Weekly: Where we highlight the movers and the losers, the upgrades and the downgrades, the top stories and opportunities in the trillion dollar REIT and real asset industry. Subscribe here.

Mining Weekly: Get an insider's edge with news, analysis, and commentary on what’s shaping the mining and commodities industry that powers the global economy. Subscribe here.